These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17536342)

  • 41. Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest.
    Moretto R; Rossini D; Zucchelli G; Lonardi S; Bergamo F; Santini D; Cupini S; Tomasello G; Caponnetto S; Zaniboni A; Antoniotti C; Pietrantonio F; Buonadonna A; Marmorino F; Bordonaro R; Fea E; Tamburini E; Boccaccino A; Grande R; Aprile G; Falcone A; Cremolini C
    Eur J Cancer; 2020 Nov; 139():81-89. PubMed ID: 32979645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seeing the forest through the trees: a systematic review of the safety and efficacy of combination chemotherapies used in the treatment of metastatic colorectal cancer.
    Bekaii-Saab T; Wu C
    Crit Rev Oncol Hematol; 2014 Jul; 91(1):9-34. PubMed ID: 24534706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New chemotherapeutic strategies in colorectal cancer.
    Moehler M; Teufel A; Galle PR
    Recent Results Cancer Res; 2005; 165():250-9. PubMed ID: 15865041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies.
    Goldstein DA; Zeichner SB; Bartnik CM; Neustadter E; Flowers CR
    Clin Colorectal Cancer; 2016 Mar; 15(1):1-6. PubMed ID: 26541320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Irinotecan as palliative chemotherapy for metastatic colorectal cancer: evolving tactics following initial treatment.
    Mitry E; Lièvre A; Bachet JB; Rougier P
    Int J Colorectal Dis; 2009 Jun; 24(6):605-12. PubMed ID: 19221763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer.
    McLean J; Rho YS; Kuruba G; Mamo A; Gilabert M; Kavan T; Panasci L; Melnychuk D; Batist G; Kavan P
    Clin Colorectal Cancer; 2016 Jun; 15(2):135-40. PubMed ID: 26553578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sequencing of treatment in metastatic colorectal cancer: where to fit the target.
    Temraz S; Mukherji D; Shamseddine A
    World J Gastroenterol; 2014 Feb; 20(8):1993-2004. PubMed ID: 24616571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiosensitizing Effects of Irinotecan versus Oxaliplatin Alone and in Combination with 5-Fluorouracil on Human Colorectal Cancer Cells.
    Frerker B; Bock F; Cappel ML; Kriesen S; Klautke G; Hildebrandt G; Manda K
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Palliative treatment of unresectable metastatic colorectal cancer.
    Fornaro L; Masi G; Loupakis F; Vasile E; Falcone A
    Expert Opin Pharmacother; 2010 Jan; 11(1):63-77. PubMed ID: 20001430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Metastatic colorectal cancer: To stop or not to stop?].
    Artru P; Bennouna J; Lievre A; Ducreux M; Lledo G
    Bull Cancer; 2018 Apr; 105(4):408-414. PubMed ID: 29477654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytotoxic chemotherapy for advanced colorectal cancer. Recent advances in management.
    Kopetz S; Hoff PM
    Oncology (Williston Park); 2005 Nov; 19(13 Suppl 6):11-7. PubMed ID: 16502665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Posterior Reversible Encephalopathy Syndrome after a Variety of Combined Chemotherapies Containing Bevacizumab for Metastatic Colon Cancer.
    Katada E; Mitsui A; Sasaki S; Uematsu N; Anan C
    Intern Med; 2018 Aug; 57(16):2403-2407. PubMed ID: 29526944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic treatment of colorectal cancer in Serbia: what have we done and what can we offer in the new century?
    Popov I
    Acta Chir Iugosl; 2004; 51(2):117-21. PubMed ID: 15771302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs.
    Barreto R; Waning DL; Gao H; Liu Y; Zimmers TA; Bonetto A
    Oncotarget; 2016 Jul; 7(28):43442-43460. PubMed ID: 27259276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy for metastatic colorectal cancer.
    Drug Ther Bull; 2002 Jul; 40(7):49-52. PubMed ID: 12154490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meta-analysis of new treatment strategies for metastatic colorectal cancer.
    Parvez T; Mahrous AR; Fawazi A
    J Coll Physicians Surg Pak; 2004 Oct; 14(10):638-42. PubMed ID: 15456561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of sequential chemotherapy of FOLFIRI/FOLFOX on the endocrine axes of ACTH-cortisol and renin-angiotensin-aldosterone.
    Huang C; Jiang Y; Duan G; Li Z; Chen L; Wang X
    J Neurooncol; 2012 Jul; 108(3):485-90. PubMed ID: 22451195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Chemotherapy of colorectal cancer--which therapy is justified for elderly patients?].
    Honecker F; Wedding U; Kolb G; Bokemeyer C
    Onkologie; 2001 Feb; 24(1):87-94. PubMed ID: 11441288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.
    Poultsides GA; Servais EL; Saltz LB; Patil S; Kemeny NE; Guillem JG; Weiser M; Temple LK; Wong WD; Paty PB
    J Clin Oncol; 2009 Jul; 27(20):3379-84. PubMed ID: 19487380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measures to mitigate treatment-related toxicities in third-line metastatic colorectal cancer.
    Ducreux M
    Clin Adv Hematol Oncol; 2021 Dec; 19 Suppl 24(12):6-11. PubMed ID: 35289797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.